Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GABRP | O00591 | 1/20 | 0.32 |
| ▸ | GABRD | O14764 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22961026 | 0.85 | DHFR (0.37) | NOS3NOS1NOS2PARP1DHFR | |
| SCHEMBL22961170 | 0.85 | NOS3 (0.37) | NOS3NOS1NOS2DHFRNPC1 | |
| SCHEMBL17553802 | 0.85 | KDM4E (0.40) | NOS3NOS1NOS2DHFRKDM4E | |
| SCHEMBL10175396 | 0.79 | PARP1 (0.35) | NOS3NOS1NOS2PARP1DHFR | |
| SCHEMBL12240485 | 0.79 | NOS3 (0.42) | NOS3NOS1NOS2SMN1; SMN2KDM4E | |
| SCHEMBL10310085 | 0.79 | NOS3 (0.38) | NOS3NOS1NOS2PARP1DHFR | |
| SCHEMBL7115171 | 0.77 | PARP1 (0.37) | NOS3NOS1NOS2PARP1DHFR | |
| SCHEMBL18546639 | 0.77 | NOS3 (0.32) | NOS3NOS1NOS2 | |
| Ammonia Solution, Strong SCHEMBL29819798 | 0.76 | TP53 (0.31) | PARP1 | |
| SCHEMBL16421188 | 0.76 | PARP1 (0.33) | NOS3NOS1NOS2PARP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779557-B | Corrosion inhibiting compositions for reducing corrosion in environments containing elemental sulfur and/or polysulfides | 艺康美国股份有限公司 | 2020-12-25 | — | — | CN | claimed |
| US-10604710-B2 | Corrosion inhibiting compositions to mitigate corrosion in environments containing elemental sulfur and/or polysulfides | ECOLAB USA INC. (US) | 2020-03-31 | — | — | US | claimed |
| EP-3420120-A1 | CORROSION INHIBITING COMPOSITIONS TO MITIGATE CORROSION IN ENVIRONMENTS CONTAINING ELEMENTAL SULFUR AND/OR POLYSULFIDES | Ecolab USA Inc. (US) | 2019-01-02 | — | — | EP | claimed |
| US-20170247798-A1 | CORROSION INHIBITING COMPOSITIONS TO MITIGATE CORROSION IN ENVIRONMENTS CONTAINING ELEMENTAL SULFUR AND/OR POLYSULFIDES | APERGY BMCS ACQUISITION CORP | 2017-08-31 | — | — | US | claimed |
| EP-4646465-A2 | CALCIUM BASED NANOPARTICLE CORROSION INHIBITOR ADDITIVES | ChampionX LLC (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2025106251-A1 | PARAFFIN BASED CORROSION INHIBITOR COMPOSITIONS AND USES THEREOF | CHAMPIONX LLC (US) | 2025-05-22 | — | — | WO | disclosed |
| US-20250154363-A1 | PARAFFIN BASED CORROSION INHIBITOR COMPOSITIONS AND USES THEREOF | CHAMPIONX LLC | 2025-05-15 | — | — | US | disclosed |
| WO-2024226740-A2 | CALCIUM BASED NANOPARTICLE CORROSION INHIBITOR ADDITIVES | CHAMPIONX LLC (US) | 2024-10-31 | — | — | WO | disclosed |
| US-20240360323-A1 | CALCIUM BASED NANOPARTICLE CORROSION INHIBITOR ADDITIVES | CHAMPIONX LLC | 2024-10-31 | — | — | US | disclosed |
| US-20240044016-A1 | COMPOSITIONS AND METHODS FOR METAL WEAR LOSS INHIBITION | CHAMPIONX LLC | 2024-02-08 | — | — | US | disclosed |
| WO-2024009232-A1 | SUBSTITUTED N-(PYRIDIN-2-YL)ACETAMIDE DERIVATIVES AS CDK12/13 INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2024-01-11 | — | — | WO | disclosed |
| US-20230182414-A1 | Method for Preparing Fiber-Reinforced Parts Based on Cyanate Ester/Epoxy Blends | ARXADA AG (CH) | 2023-06-15 | — | — | US | disclosed |
| US-20090275751-A1 | 1,2-DIHYDROPYRIDINE COMPOUNDS, MANUFACTURING METHOD THEREOF AND USE THEREOF | NAGATO SATOSHI | 2009-11-05 | — | — | US | disclosed |
| US-7563811-B2 | 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-07-21 | — | — | US | disclosed |
| WO-2008157234-A2 | MONO AND BIS-ESTER DERIVATIVES OF PYRIDINIUM AND QUINOLINIUM COMPOUNDS AS ENVIRONMENTALLY FRIENDLY CORROSION INHIBITORS | NALCO COMPANY (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080308770-A1 | MONO AND BIS-ESTER DERIVATIVES OF PYRIDINIUM AND QUINOLINIUM COMPOUNDS AS ENVIRONMENTALLY FRIENDLY CORROSION INHIBITORS | ECOLAB USA INC. | 2008-12-18 | — | — | US | disclosed |
| US-20030064989-A1 | Inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-04-03 | — | — | US | disclosed |
| US-5223160-A | Mixture of ether alcohol and amine compound | NALCO CHEMICAL COMPANY | 1993-06-29 | — | — | US | disclosed |
| US-5009799-A | Ethoxylated fatty amine and betaine inner salts, alkyne radical contining alcohol, pyridine quaternary ammonium salt | NALCO CHEMICAL COMPANY (US) | 1991-04-23 | — | — | US | disclosed |
| US-4554090-A | REACXTION PRODUCT OF N-HETEROCYCLE, ALDEHYDE, PHOSPHORUS COMPOUND | JONES L W | 1985-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10604710-B2 | Corrosion inhibiting compositions to mitigate corrosion in environments containing elemental sulfur and/or polysulfides | SLC7A11, TST, FECH | NOS3 662/4885NOS1 535/4885NOS2 465/4885 |
| US-20030064989-A1 | Inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction | MYH10, MYLK, MKI67 | NOS3 416/4885NOS1 1076/4885NOS2 1820/4885 |
| US-20080308770-A1 | MONO AND BIS-ESTER DERIVATIVES OF PYRIDINIUM AND QUINOLINIUM COMPOUNDS AS ENVIRONMENTALLY FRIENDLY CORROSION INHIBITORS | AOC2, AOC3, CBR3 | NOS3 70/4885NOS1 78/4885NOS2 48/4885 |
| US-20090275751-A1 | 1,2-DIHYDROPYRIDINE COMPOUNDS, MANUFACTURING METHOD THEREOF AND USE THEREOF | GRIK1, GRIK2, GRIK5 | NOS3 1717/4885NOS1 1370/4885NOS2 1789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.